European drug authorities have issued recommendations to address ongoing shortages in glucagon-like peptide 1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity. These […]

Should a patient with high lipoprotein a, or Lp(a), be started on low-dose aspirin? This is the conundrum facing many physicians and patients, but even getting […]

ORLANDO, Florida — What to prioritize first in managing early diabetes? That was the question debated on an expert panel at the American Diabetes Association (ADA) […]

Orlando, FLORIDA — Use of continuous glucose monitoring (CGM) and automated insulin delivery (AID) systems doesn’t guarantee achievement of A1c targets or avoidance of severe hypoglycemia […]

“You had to pay the fee, or the doctor wasn’t going to see you anymore.” That was the takeaway for Terri Marroquin of Midland, Texas, when […]

CHICAGO — An abbreviated course of azacitidine for 7 days plus venetoclax for 7 days showed similar efficacy to a standard hypomethylating agent plus venetoclax doublets […]

Analysis of finger sweat detected isoniazid in adults with tuberculosis (TB) for ≤ 6 hours after administration, based on data from a new pilot study. Risk […]

Individuals with anxiety have at least a twofold higher risk of developing Parkinson’s disease (PD) than those without anxiety, new research suggested. Investigators drew on 10-year […]

VIENNA — While there is no doubt that some people with psoriatic arthritis (PsA) have axial symptoms, data presented at the European Alliance of Associations for […]